Inventor
HALL RALPH
US14 patents
⚠️ This page may combine multiple inventors who share the name “HALL RALPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MR3 MEDICAL LLC
7 patentsUS10549102B2Feb 4, 2020
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals
MR3 MEDICAL LLC0 citations51
US9943692B2Apr 17, 2018
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals
MR3 MEDICAL LLC0 citations51
US9610446B2Apr 4, 2017
System and method for stimulating the heart using sub-threshold biphasic stimulation
MR3 MEDICAL LLC0 citations51
US9566445B2Feb 14, 2017
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals
MR3 MEDICAL LLC0 citations51
US9566446B2Feb 14, 2017
System and method for stimulating the heart via storage of multi-waveforms in a cardiac stimulation device
MR3 MEDICAL LLC0 citations51
US9446247B2Sep 20, 2016
System and method for stimulating the heart using sub-threshold biphasic stimulation
MR3 MEDICAL LLC0 citations51
US9616236B2Apr 11, 2017
System and method for stimulating the heart via the vagus nerve
MR3 MEDICAL LLC0 citations41
SMITHKLINE BEECHAM CORP
4 patentsUS7323472B2Jan 29, 2008
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
SMITHKLINE BEECHAM CORP20 citations92
US7314881B2Jan 1, 2008
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
SMITHKLINE BEECHAM CORP17 citations92
US7314934B2Jan 1, 2008
4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
SMITHKLINE BEECHAM CORP9 citations83
US7053099B1May 30, 2006
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
SMITHKLINE BEECHAM CORP2 citations60